Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Stuart

Showing results (291-300 of 313) with videos related to

Pageof 32
Sort By:
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Nature Structural & Molecular Biology|July 15, 2020
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2Jiandong Huo, Audrey Le Bas, Reinis R Ruza, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Nature Structural & Molecular Biology|February 4, 2021
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2Jiandong Huo, Audrey Le Bas, Reinis R Ruza, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 23, 2020
SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020Sheila F Lumley, David W Eyre, Anna L McNaughton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2021
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination StatusSheila F Lumley, Gillian Rodger, Bede Constantinides, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 2, 2024
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in VietnamTran Tan Thanh, Nguyen Thi Kha Tu, Lam Anh Nguyet, et al.
Nature Structural & Molecular Biology|August 2, 2020
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patientDaming Zhou, Helen M E Duyvesteyn, Cheng-Pin Chen, et al.
Pageof 32

Showing results (291-300 of 313) with videos related to

Sort By:
Pageof 32
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Nature Structural & Molecular Biology|July 15, 2020
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2Jiandong Huo, Audrey Le Bas, Reinis R Ruza, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Nature Structural & Molecular Biology|February 4, 2021
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2Jiandong Huo, Audrey Le Bas, Reinis R Ruza, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 23, 2020
SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020Sheila F Lumley, David W Eyre, Anna L McNaughton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2021
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination StatusSheila F Lumley, Gillian Rodger, Bede Constantinides, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 2, 2024
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in VietnamTran Tan Thanh, Nguyen Thi Kha Tu, Lam Anh Nguyet, et al.
Nature Structural & Molecular Biology|August 2, 2020
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patientDaming Zhou, Helen M E Duyvesteyn, Cheng-Pin Chen, et al.
Pageof 32